Clementia Pharmaceuticals Inc (CMTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -58,126 | -115,455 | -57,512 | -75,897 |
| Depreciation Amortization | 212 | 205 | 173 | 149 |
| Other Working Capital | 5,538 | -1,712 | 1,046 | 2,066 |
| Other Operating Activity | 3,231 | 81,396 | 37,466 | 56,059 |
| Operating Cash Flow | $-49,145 | $-35,567 | $-18,828 | $-17,623 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 30,000 | -75,000 | -30,000 | 0 |
| PPE Investments | -4 | -20 | -28 | -49 |
| Purchase Sale Intangibles | -136 | -1,000 | N/A | -116 |
| Other Investing Activity | 2,233 | -186 | 96 | -11 |
| Investing Cash Flow | $32,228 | $-75,206 | $-29,932 | $-60 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 80,955 | 137,897 | N/A | 50 |
| Other Financing Activity | -5,173 | -366 | 0 | 70,621 |
| Financing Cash Flow | $75,782 | $137,531 | $N/A | $70,672 |
| Exchange Rate Effect | -123 | 38 | 88 | -385 |
| Beginning Cash Position | 36,230 | 9,435 | 58,107 | 5,504 |
| End Cash Position | 94,973 | 36,230 | 9,435 | 58,107 |
| Net Cash Flow | $58,742 | $26,796 | $-48,672 | $52,603 |
| Free Cash Flow | ||||
| Operating Cash Flow | -49,145 | -35,567 | -18,828 | -17,623 |
| Capital Expenditure | -4 | -20 | -28 | -49 |
| Free Cash Flow | -49,149 | -35,587 | -18,856 | -17,672 |